Cargando…
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature
Olmesartan, an angiotensin II receptor antagonist used to treat hypertension, is associated with few adverse effects. Here, a case of severe sprue-like enteropathy and acute kidney injury is described in a 68-year-old male taking olmesartan for 3-4 years. He presented to hospital with a five-week hi...
Autores principales: | Kulai, Tasha, Arnason, Thomas, MacIntosh, Donald, Igoe, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904703/ https://www.ncbi.nlm.nih.gov/pubmed/27446852 http://dx.doi.org/10.1155/2016/6091571 |
Ejemplares similares
-
Esophageal Variceal Hemorrhage Secondary to Post-Polycythemic Myelofibrosis
por: Motomura, Douglas, et al.
Publicado: (2018) -
Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
por: Eusébio, Marta, et al.
Publicado: (2015) -
Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue—A Case Report and Brief Literature Review
por: Desruisseaux, Claudine, et al.
Publicado: (2016) -
An unusual duodenal cloverleaf
por: Tursi, Antonio
Publicado: (2014) -
Duodenal siderosis: a rare clinical finding in a patient with duodenal inflammation
por: Kothadia, Jiten P., et al.
Publicado: (2016)